切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2019, Vol. 08 ›› Issue (04) : 325 -328. doi: 10.3877/cma.j.issn.2095-3224.2019.04.001

所属专题: 指南与规范 文献 指南共识

指南与共识

中国Ⅱ、Ⅲ期结直肠癌县域医师诊疗指南-内科部分(2019版草案)
中国医师协会结直肠肿瘤专业委员会内科专委会   
  • 收稿日期:2019-07-22 出版日期:2019-08-25

Guidelines for county physicians in diagnosis and treatment of stage Ⅱ and Ⅲ colorectal cancer in China-Internal Medicine Section (2019 edition)

Professional Committee of Internal Medicine, Colorectal Cancer Committee of Chinese Medical Doctor Association   

  • Received:2019-07-22 Published:2019-08-25
引用本文:

中国医师协会结直肠肿瘤专业委员会内科专委会. 中国Ⅱ、Ⅲ期结直肠癌县域医师诊疗指南-内科部分(2019版草案)[J/OL]. 中华结直肠疾病电子杂志, 2019, 08(04): 325-328.

Professional Committee of Internal Medicine, Colorectal Cancer Committee of Chinese Medical Doctor Association. Guidelines for county physicians in diagnosis and treatment of stage Ⅱ and Ⅲ colorectal cancer in China-Internal Medicine Section (2019 edition)[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2019, 08(04): 325-328.

国家癌症中心2019年发布的数据显示,我国结直肠癌的发病率及死亡率均呈上升趋势,主要与我国结直肠癌基本诊疗规范落实欠缺,整体诊治水平偏低有关。特别在基层级医院,由于各种资源配置相对落后,无法完全按照国际诊疗指南进行诊治,医疗水平参差不齐。鉴于县域级医院是多数结直肠癌患者的首次就诊单位,需要服务的人群基数大,制定适合于县域级医院的结直肠癌诊疗指南,提高基层医疗服务质量尤为重要。为此,中国医师协会结直肠肿瘤专业委员会内科治疗专委会起草、讨论并最终发布2019中国Ⅱ、Ⅲ期结直肠癌县域医师诊疗指南内科部分,以规范Ⅱ、Ⅲ期结直肠癌的内科治疗。

According to the data released by the National Cancer Center in 2019, the morbidity and mortality of colorectal cancer in China are on the rise. This mainly related to the lack of basic medical treatment standards, and the overall level of diagnosis and treatment is still low. Especially in county-level hospitals, due to the relatively backward allocation of various resources, it is impossible to completely follow the international treatment guidelines, and the medical level is uneven. Since county-level hospitals are the first unit of treatment for most patients with colorectal cancer, and the number of people who need services is large, it is especially important to develop guidelines for colorectal cancer diagnosis and treatment suitable for county-level hospitals. To this end, Professional Committee of Internal Medicine, Colorectal Cancer Committee of Chinese Medical Doctor Association drafted, discussed, and finally released Guidelines Internal Medicine Section for county physicians in diagnosis and treatment of stageⅡ and Ⅲ colorectal cancer in China, to standardize stage Ⅱ and Ⅲ colorectal cancer medical treatment.

表1 Ⅱ期结肠癌辅助化疗推荐
表2 Ⅲ期结肠癌辅助化疗推荐
表3 直肠癌术后辅助化疗推荐
中国Ⅱ、Ⅲ期结直肠癌县域医师诊疗指南-内科部分(2019版草案)专家名单(按姓氏拼音排序)
[1]
Sargent DJ, Marsoni S, Monges G, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil based adjuvant therapy in colon cancer [J]. J Clin Oncol, 2010, 28(20): 3219-3226.
[2]
Iveson T, Sobrero AF, Yoshino T, et al. Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stageⅡ colorectal cancer (CC) [J].J Clin Oncol, 2019, 37(15_suppl): pp 3501.
[3]
Grothey A, Sobrero AF, Shields AF, et al. Duration of adjuvant chemotherapy for stageⅢ colon cancer [J]. N Engl J Med, 2018, 378(13): 1177-1188.
[4]
Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer [J]. N Engl J Med, 2006, 355(11): 1114-1123.
[5]
Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].Ann Oncol, 2017, 28(suppl_4): iv22-iv40.
[1] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[2] 王宇, 徐芳泉, 周旋, 姚晓峰, 李强. 不断提高分化型甲状腺癌根治性切除规范化[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 473-476.
[3] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[4] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[5] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[6] 中国抗癌协会, 中国抗癌协会大肠癌专业委员会. 中国恶性肿瘤整合诊治指南-肛管癌(2024 版)[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 441-449.
[7] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[8] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[9] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[10] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
[11] 中国抗癌协会结直肠肿瘤整合康复专业委员会, 北京癌症防治学会直肠癌新辅助治疗专业委员会. 直肠癌新辅助治疗相关恶心、呕吐副反应的预防、诊断及治疗指南[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 353-361.
[12] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[13] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[14] 周学锋, 董哲毅, 冯哲, 蔡广研, 陈香美. 糖尿病肾脏疾病中西医结合诊疗指南计划书[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 301-305.
[15] 李茂军, 唐彬秩, 吴青, 阳倩, 梁小明, 邹福兰, 黄蓉, 陈昌辉. 新生儿呼吸窘迫综合征的管理:多国指南/共识及RDS-NExT workshop 共识陈述简介和评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 607-617.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?